Blue Water Vaccines, Inc. BWV
Day range unavailable
52-week range unavailable
- Market cap
- 3.41M
- Shares out
- 18.90M
- Forward P/E
- -0.21
- Analysts
- Hold
- Price target
- 9.00 (+4894.5%)
- Earnings date
- Nov 17, 2023
Key statistics
- Enterprise value
- 8.71M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.31
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -18.10M
- Total cash
- 7.65M
- Total debt
- 12.92M
- Return on equity
- -101.63%
- Short % of float
- 0.17%
- 50-day average
- 0.278868
- 200-day average
- 0.74317
Analyst view
Consensus: hold
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 17, 2023
Expected Nov 17, 2023. Consensus EPS estimate -0.21.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 17, 2023 | Sep 1, 2023 | 0.00 | — | — | — |
| Oct 20, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
| May 12, 2023 | Mar 1, 2023 | -0.21 | — | — | — |
| Mar 9, 2023 | Dec 1, 2022 | -0.25 | — | — | — |
| Nov 10, 2022 | Sep 1, 2022 | 0.00 | — | — | — |
| Aug 15, 2022 | Jun 1, 2022 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 12, 2023 | Maxim Group | down | Buy | Hold |
| Apr 25, 2023 | HC Wainwright & Co. | main | — | Buy |
| Jan 31, 2023 | HC Wainwright & Co. | reit | — | Buy |
| Dec 8, 2022 | HC Wainwright & Co. | init | — | Buy |
| Dec 7, 2022 | Maxim Group | init | — | Buy |
About Blue Water Vaccines, Inc.
Blue Water Biotech, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns ENTADFI, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Vaccines, Inc. and changed its name to Blue Water Biotech, Inc. in April 2023. Blue Water Biotech, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- bwbioinc.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on BWV — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CINCINNATI CORNERSTONE INVESTORS BWV I LLC | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 22, 2022 | 0 |
| GARFIELD JON M | Chief Financial Officer | Stock Award(Grant) | May 8, 2023 | 100,000 |
| HENDERSON ERIN | Officer | Stock Award(Grant) | May 8, 2023 | 174,752 |
| HERNANDEZ JOSEPH | Chief Executive Officer | Stock Award(Grant) | May 8, 2023 | 2,800,350 |
| JEREMIC VUK | Director | Stock Award(Grant) | May 30, 2023 | 6,360 |
| RAMDEEN TIMOTHY R. | Director | Stock Award(Grant) | May 30, 2023 | 6,360 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| American Financial Group Inc. | 9.06% | 1,440,927 | 1.63M | Jun 29, 2023 |
| Cetera Advisor Networks LLC | 1.72% | 273,700 | 309.28K | Jun 29, 2023 |
| Vanguard Group Inc | 1.11% | 177,283 | 200.33K | Jun 29, 2023 |
| Bank of America Corporation | 0.79% | 125,000 | 141.25K | Jun 29, 2023 |
| Fifth Third Bancorp | 0.60% | 96,196 | 108.70K | Jun 29, 2023 |
| Blackrock Inc. | 0.34% | 53,561 | 60.52K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 0.80% | 127,574 | 144.16K | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 0.31% | 49,709 | 56.17K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.26% | 41,924 | 33.75K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.04% | 6,658 | 5.36K | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.02% | 3,818 | 3.07K | May 30, 2023 |